Skip to main content

Bevacizumab-induced reversible posterior leukoencephalopathy syndrome and successful retreatment in a patient with glioblastoma.

Publication ,  Journal Article
Lou, E; Turner, S; Sumrall, A; Reardon, DA; Desjardins, A; Peters, KB; Sampson, JH; Friedman, HS; Vredenburgh, JJ
Published in: J Clin Oncol
October 1, 2011

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Clin Oncol

DOI

EISSN

1527-7755

Publication Date

October 1, 2011

Volume

29

Issue

28

Start / End Page

e739 / e742

Location

United States

Related Subject Headings

  • Temozolomide
  • Posterior Leukoencephalopathy Syndrome
  • Oncology & Carcinogenesis
  • Middle Aged
  • Humans
  • Glioblastoma
  • Female
  • Dacarbazine
  • Brain Neoplasms
  • Bevacizumab
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lou, E., Turner, S., Sumrall, A., Reardon, D. A., Desjardins, A., Peters, K. B., … Vredenburgh, J. J. (2011). Bevacizumab-induced reversible posterior leukoencephalopathy syndrome and successful retreatment in a patient with glioblastoma. J Clin Oncol, 29(28), e739–e742. https://doi.org/10.1200/JCO.2011.36.1865
Lou, Emil, Scott Turner, Ashley Sumrall, David A. Reardon, Annick Desjardins, Katherine B. Peters, John H. Sampson, Henry S. Friedman, and James J. Vredenburgh. “Bevacizumab-induced reversible posterior leukoencephalopathy syndrome and successful retreatment in a patient with glioblastoma.J Clin Oncol 29, no. 28 (October 1, 2011): e739–42. https://doi.org/10.1200/JCO.2011.36.1865.
Lou E, Turner S, Sumrall A, Reardon DA, Desjardins A, Peters KB, et al. Bevacizumab-induced reversible posterior leukoencephalopathy syndrome and successful retreatment in a patient with glioblastoma. J Clin Oncol. 2011 Oct 1;29(28):e739–42.
Lou, Emil, et al. “Bevacizumab-induced reversible posterior leukoencephalopathy syndrome and successful retreatment in a patient with glioblastoma.J Clin Oncol, vol. 29, no. 28, Oct. 2011, pp. e739–42. Pubmed, doi:10.1200/JCO.2011.36.1865.
Lou E, Turner S, Sumrall A, Reardon DA, Desjardins A, Peters KB, Sampson JH, Friedman HS, Vredenburgh JJ. Bevacizumab-induced reversible posterior leukoencephalopathy syndrome and successful retreatment in a patient with glioblastoma. J Clin Oncol. 2011 Oct 1;29(28):e739–e742.

Published In

J Clin Oncol

DOI

EISSN

1527-7755

Publication Date

October 1, 2011

Volume

29

Issue

28

Start / End Page

e739 / e742

Location

United States

Related Subject Headings

  • Temozolomide
  • Posterior Leukoencephalopathy Syndrome
  • Oncology & Carcinogenesis
  • Middle Aged
  • Humans
  • Glioblastoma
  • Female
  • Dacarbazine
  • Brain Neoplasms
  • Bevacizumab